Metrikler
Yayın
163
Açık Erişim
14
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
2001 - 2004
2001 - 2004Tıpta Uzmanlık
Hacettepe Üniversitesi, Tıp Fakültesı, Gastroenterolojı, Türkiye
1996 - 2000
1996 - 2000Tıpta Uzmanlık
Hacettepe Üniversitesi, Tıp Fakültesı, İç Hastalıkları, Türkiye
1989 - 1996
1989 - 1996Lisans
Hacettepe Üniversitesi, Tıp Fakültesı, Türkiye
Yaptığı Tezler
2018
2018Doktora
HEV taranması ve genotiplendirilmesi
Hacettepe Üniversitesi, İç Hastalıkları, Gastroenteroloji
Yabancı Diller
C1 İleri
C1 İleriİngilizce
Sertifika, Kurs ve Eğitimler
2000
2000KPSS
Yabancı Dil
İÇ HASTALIKLARI
Araştırma Alanları
Avesis Araştırma Alanları:
Tıp, Sağlık Bilimleri, Dahili Tıp Bilimleri, İç Hastalıkları, Gastroenteroloji-(Hepatoloji)
WoS Araştırma Alanları:
Klinik Tıp (MED), Klinik Tıp, GASTROENTEROLOJİ VE HEPATOLOJİ
Scopus Araştırma Alanları:
Gastroenteroloji
Akademik Faaliyetlere Dayalı Araştırma Alanları
Avesis Araştırma Alanları
WoS Araştırma Alanları
Scopus Araştırma Alanları
Akademik Ünvanlar / Görevler
2018 - Devam Ediyor
2018 - Devam EdiyorDoç. Dr.
Hacettepe Üniversitesi, Tıp Fakültesi (Türkçe), Dahili Tıp Bilimleri Bölümü
Yönetimsel Görevler
2018 - Devam Ediyor
2018 - Devam EdiyorAkademik Kurul Üyesi
Hacettepe Üniversitesi, Gastroenteroloji
Makaleler
Tümü (110)
SCI-E, SSCI, AHCI (75)
SCI-E, SSCI, AHCI, ESCI (89)
ESCI (8)
Scopus (91)
TRDizin (31)
Diğer Yayınlar (8)
2026
20261. Temporal trends and regional variations in hepatocellular carcinoma etiology: a multinational study across Asia
Takeuchi Y., Tateishi R., Obi S., Otsuka M., Mochizuki H., Jazag A., et al.
Hepatology International
, cilt.20, sa.2, ss.373-383, 2026 (SCI-Expanded, Scopus)
2026
20262. The role of liver biopsy for the investigation of fever of unknown origin: Insights from a small cohort
DALKILIÇ Y. E., KİKİ Z., SÖKMENSÜER C., BALABAN H. Y.
Journal of gastrointestinal and liver diseases : JGLD
, cilt.35, sa.1, ss.135-136, 2026 (SCI-Expanded, Scopus)
2026
20263. De Novo Malignancies after Liver Transplantation: A Multicenter Cohort Study of Incidence, Timing, and Outcomes
DANIŞ N., DÖNGELLİ H., ÜNEK T., Bacakoğlu A., Turan İ., Karasu A. Z., et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, cilt.37, sa.4, ss.510-523, 2026 (SCI-Expanded, Scopus, TRDizin)
2026
20264. Efficacy and tolerability of tenofovir alafenamide fumarate prophylaxis in HBV-infected individuals receiving chemo/ immunosuppressive therapy
Dilber F., Durak S., Unsal Y., DEMİR M., Yildirim A. E., Ellik Z. M., et al.
Hepatology Forum
, cilt.7, sa.1, ss.26-31, 2026 (Scopus)
2026
20265. No Plaque Detected in the Proper Hepatic Artery: A Comparison with Other Abdominal Arteries
TAŞKINDERE ABBASOĞLU T., Abbasoğlu A., KARÇAALTINCABA M., BALABAN H. Y., Tokgözoğlu L., DAĞ O., et al.
Bratislava Medical Journal
, 2026 (SCI-Expanded, Scopus)
2025
20256. Novel prostaglandin and isoprostane panel for evaluating Wilson's Disease
Polat M. B., Durukan B. M., Israfilov S., YALÇIN ÇAKMAKLI G., İDİLMAN İ. S., DAĞ O., et al.
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI
, cilt.50, sa.6, ss.870-877, 2025 (SCI-Expanded, Scopus, TRDizin)
2025
20257. Commercial real-time PCR kit results for the detection of Helicobacter pylori and clarithromycin resistance in stool samples
Inal N., Sahin T., BALABAN H. Y., ŞİMŞEK C., Simsek H., Akyon Y.
INDIAN JOURNAL OF MEDICAL MICROBIOLOGY
, cilt.57, 2025 (SCI-Expanded, Scopus)
2025
20258. Pre-transplant predictors of 3-Month survival following liver transplantation for acute liver failure in adult and pediatric patients in Turkiye
Turan I., Akarca U. S., Aladag M., Harputluoglu M., YILMAZ S., Gencdal G., et al.
SCIENTIFIC REPORTS
, cilt.15, sa.1, 2025 (SCI-Expanded, Scopus)
2025
20259. Performance Evaluation of Gastroenterology Specific Language Model GastroGPT on Hepatocellular Carcinoma Management
Şimşek C., Üçdal M. T., Yazarkan Y., Durak M. B., Balaban H. Y.
İç Hastalıkları Dergisi , cilt.1, sa.2, ss.1-9, 2025 (Hakemli Dergi)
2025
202510. Evaluating the Role of Artificial Intelligence in Making Clinical Decisions for Treating Acute Pancreatitis
BALABAN H. Y., ÜÇDAL M., DURAK M. B., ŞİMŞEK C.
JOURNAL OF CLINICAL MEDICINE
, cilt.14, 2025 (SCI-Expanded, Scopus)
2025
202511. Cytomegalovirus Management in Solid Organ Transplant Recipients
BALABAN H. Y., KÖKSOY B., ŞENDUR İ.
OBM TRANSPLANTATION , cilt.9, 2025 (Scopus)
2025
202512. The Liver in View of Acupuncture
FIRAT A., BALABAN H. Y.
CURRENT HEPATOLOGY REPORTS
, sa.1, 2025 (ESCI)
2025
202513. Astroviruses and celiac disease: a preliminary study into potential environmental triggers
POLAT C., ŞAHİN T., ŞİMŞEK C., TEKİN İ. E., İsrafilov S., SÖKMENSÜER C., et al.
Acta Medica , 2025 (TRDizin)
2025
202514. Late Effects Following Hematopoietic Stem Cell Transplantation Among Childhood Transplant Survivors with Fanconi Anemia
Ozkocer C., Visal Okur F. V., Demirbilek H., Altintas B., Cetin N., Kuskonmaz B. B., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.42, sa.1, ss.15-24, 2025 (SCI-Expanded, Scopus, TRDizin)
2025
202515. Muscle Strength and Cardiovascular Health in MASLD: A Prospective Study
Kumbaroglu B. F., Balaban Y. H., Duger T.
MEDICINA-LITHUANIA
, cilt.61, sa.2, 2025 (SCI-Expanded, Scopus)
2025
202516. Is high AFP associated with liver diseases in ataxia-telangiectasia and ataxia-oculomotor apraxia?
Ismayilov R., ÖZÜM T., ERSAL DEREGÖZÜ E., Israfilov S., Abdurrahimli N., YALÇIN ÇAKMAKLI G., et al.
HEPATOLOGY FORUM
, cilt.6, sa.1, ss.11-15, 2025 (ESCI, TRDizin)
2025
202517. Otoimmün hepatit epidemiyoloji ve patogenezi.
ÖZKAN A., BALABAN H. Y.
Otoimmün hepatit epidemiyoloji ve patogenezi. Günşar F, editör. Otoimmün Karaciğer Hastalıkları , 2025 (TRDizin)
2025
202518. Ribociclib-induced autoimmune-like hepatitis: a case report
KAVGACI G., ŞAHİN T. K., SÖKMENSÜER C., BALABAN H. Y., AKSOY S.
JOURNAL OF CHEMOTHERAPY
, cilt.37, sa.8, ss.741-746, 2025 (SCI-Expanded, Scopus)
2024
202419. Prospective evaluation of patients with non-cirrhotic portal hypertension: A single-centre study
Ucdal M., ŞİMŞEK C., Durak B., BALABAN H. Y.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
, cilt.60, sa.10, ss.1487-1488, 2024 (SCI-Expanded, Scopus)
2024
202420. Changing Trends in the Etiology of Cirrhosis in Türkiye: A Multicenter Nationwide Study
ÜÇBİLEK E., Yildirim A. E., Ellik Z., TURAN İ., HAKTANIYAN B., Orucu B., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.35, sa.10, 2024 (SCI-Expanded, Scopus)
2024
202421. Evaluation of risk for hepatitis B virus reactivation in patients with psoriasis treated with biologic therapies: a single-center retrospective study
Tabak G. H., AKDOĞAN N., DOĞAN GÜNAYDIN S., PARLAR Y. E., BALABAN H. Y., ŞİMŞEK H.
ARCHIVES OF DERMATOLOGICAL RESEARCH
, cilt.316, sa.5, 2024 (SCI-Expanded, Scopus)
2024
202422. Inborn Errors of Immunity in Adults with Autoimmune Liver Diseases.
Ayar Ş. N., Aytekin E. S., Şimşek C., Dağ O., Çağdaş D. N., Balaban Y. H.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, cilt.35, sa.7, ss.560-567, 2024 (SCI-Expanded, Scopus, TRDizin)
2024
202423. Selective Immunoglobulin M Deficiency in Patients with Autoimmune Liver Diseases
Balaban Y. H., Ismail M., AYAR Ş. N.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.35, sa.6, ss.505-508, 2024 (SCI-Expanded, Scopus, TRDizin)
2024
202424. Vision for the Journal in the Second Quarter of 21st Century
BALABAN H. Y., Sheikh Mohammad Fazle A., Mamun A. M.
Euroasian journal of hepato-gastroenterology
, cilt.14, 2024 (Hakemli Dergi)
2024
202425. Changing trends in the etiology of liver transplantation in Turkiye: A multicenter study
Akarsu M., DOLU S., Harputluoglu M., YILMAZ S., Akyildiz M., Gencdal G., et al.
Hepatology Forum
, cilt.5, sa.1, ss.3-6, 2024 (Scopus, TRDizin)
2024
202426. Are dietary factors associated with cardiometabolic risk factors in patients with non-alcoholic fatty liver disease?
TOPAL G. G., Sevim S., GÜMÜŞ D., BALABAN H. Y., KARÇAALTINCABA M., KIZIL M.
PEERJ
, cilt.12, 2024 (SCI-Expanded, Scopus)
2024
202427. Commercial Real-Time PCR Kit Results for the Detection of Helicobacter pylori and Clarithromycin Resistance in Stool Samples
BALABAN H. Y., İNAL N., ŞİMŞEK C., ŞİMŞEK H., AKYÖN YILMAZ Y.
Research Square
, 2024 (Hakemli Dergi)
2024
202428. Evidence-Based Herbal Treatments in Liver Diseases
Karakus M., Altintas D., BALABAN H. Y., Caliskan U. K.
Hepatology Forum
, cilt.5, sa.1, ss.50-60, 2024 (Scopus, TRDizin)
2023
202329. A novel brick on the wall of non-alcoholic fatty liver disease (NAFLD): Nuclear receptor coactivator 4 (NCOA4)
Üçdal M. T., Burus A., Celtikci B., Yasemin Balaban H. Y.
MEDICAL HYPOTHESES
, cilt.181, 2023 (SCI-Expanded, Scopus)
2023
202330. Risk of Bleeding After Percutaneous Endoscopic Gastrostomy in Patients Using Antithrombotic Drugs
PARLAR Y. E., Mustafayev F., Vahabov C., ŞAHİN T., İsrafilov S., KESKİN O., et al.
Surgical Laparoscopy, Endoscopy and Percutaneous Techniques
, cilt.33, sa.5, ss.540-542, 2023 (SCI-Expanded, Scopus)
2023
202331. Liver immunity, autoimmunity, and inborn errors of immunity
PARLAR Y. E., AYAR Ş. N., ÇAĞDAŞ AYVAZ D. N., BALABAN H. Y.
World Journal of Hepatology
, cilt.15, sa.1, ss.52-67, 2023 (ESCI, Scopus)
2023
202332. TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease
YILMAZ Y., ZEYBEL M., ADALI G., COŞAR A., SERTESEN E., SÜMER H., et al.
HEPATOLOGY FORUM
, cilt.4, ss.1-32, 2023 (ESCI, Scopus, TRDizin)
2023
202333. Clinical anatomy of hepatic vessels by computed tomography angiography: A minireview Firat A, Abbasoglu TT, Karcaaltincaba M, Balaban YH. Clinical anatomy of hepatic vessels by computed tomography angiography: A minireview.
FIRAT A., Taşkındere Abbasoğlu T., KARÇAALTINCABA M., BALABAN H. Y.
WORLD JOURNAL OF RADIOLOGY , cilt.15, sa.1, ss.1-9, 2023 (Hakemli Dergi)
2023
202334. Clinical anatomy of hepatic vessels by computed tomography angiography: A minireview
FIRAT A., TAŞKINDERE ABBASOĞLU T., KARÇAALTINCABA M., Balaban Y. H.
WORLD JOURNAL OF RADIOLOGY
, cilt.15, sa.1, ss.1-9, 2023 (ESCI)
2022
202235. Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome
Efe C., Kulkarni A. V., Terziroli Beretta-Piccoli B., Magro B., Friedrich Staettermayer A., Cengiz M., et al.
HEPATOLOGY
, cilt.76, sa.6, ss.1576-1586, 2022 (SCI-Expanded, Scopus)
2022
202236. SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis
Efe C., Taşçılar K., Gerussi A., Bolis F., Lammert C., Ebik B., et al.
Journal of Autoimmunity
, cilt.132, 2022 (SCI-Expanded, Scopus)
2022
202237. Characteristics of patients with hepatocellular carcinoma: A multicenter study
Guzelbulut F., KARAOĞULLARINDAN Ü., AKKIZ H., ALTINTAŞ E., DEMİRTAŞ C. Ö., Bahadir O., et al.
HEPATOLOGY FORUM
, cilt.3, sa.3, ss.71-76, 2022 (ESCI, Scopus, TRDizin)
2022
202238. Trends and causes of etiology in adult liver transplant patients: multicenter study
AKARSU M., Harputluoglu M., YILMAZ S., Gencdal G., Akyildiz M., Polat K. Y., et al.
JOURNAL OF HEPATOLOGY
, cilt.77, 2022 (SCI-Expanded, Scopus)
2022
202239. Real life efficacy and tolerability of Tenofovir alafenamde fumarate in liver transplant recipients: a multicenter study
GÖKCAN H., YAPALI S., Harputluoglu M., Ellik Z. M. L., Gokcen P., ADANIR H., et al.
JOURNAL OF HEPATOLOGY
, cilt.77, 2022 (SCI-Expanded, Scopus)
2022
202240. Hepatitis E Virus Prevalence and Associated Risk Factors in High-Risk Groups: A Cross-Sectional Study
BALABAN H. Y., ASLAN A. T., AKDOĞAN KITTANA F. N., ALP A., DAĞ O., AYAR Ş. N., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.33, sa.7, ss.615-624, 2022 (SCI-Expanded, Scopus, TRDizin)
2022
202241. Abdominal Massage in Functional Chronic Constipation: A Randomized Placebo-Controlled Trial
Dogan I. G., GÜRŞEN C., AKBAYRAK T., Balaban Y. H., Vahabov C., ÜZELPASACI E., et al.
PHYSICAL THERAPY
, cilt.102, sa.7, 2022 (SCI-Expanded, Scopus)
2022
202242. Practical points that gastrointestinal fellows should know in management of COVID-19
ŞAHİN T., ŞİMŞEK C., BALABAN H. Y.
WORLD JOURNAL OF CLINICAL CASES
, cilt.10, sa.16, ss.5133-5145, 2022 (SCI-Expanded, Scopus)
2022
202243. A rare case of DIC in a patient with Wilson's disease: D-penicillamine
PARLAR Y. E., BALABAN H. Y., MALKAN Ü. Y., DENİZ E., UYSAL F. R.
HEPATOLOGY FORUM
, cilt.3, sa.2, ss.61-63, 2022 (ESCI, Scopus, TRDizin)
2022
202244. Global multi-stakeholder endorsement of the MAFLD definition
BALABAN H. Y., YILMAZ Y.
THE LANCET. GASTROENTEROLOGY & HEPATOLOGY
, cilt.7, 2022 (SCI-Expanded, Scopus)
2022
202245. Why Should Anatomists Underline the Geometry of Some Special Structures?
FIRAT A., BALABAN H. Y.
JOURNAL OF THE ANATOMICAL SOCIETY OF INDIA
, cilt.71, sa.2, ss.158-159, 2022 (SCI-Expanded, Scopus)
2022
202246. Anatomists Should Underline the Geometry of Some Special Structures
FIRAT A., BALABAN H. Y.
TURKIYE KLINIKLERI JOURNAL OF MEDICAL SCIENCES
, cilt.42, sa.2, ss.144-145, 2022 (Scopus, TRDizin)
2022
202247. Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis
Efe C., Lammert C., Tascilar K., Dhanasekaran R., Ebik B., Higuera-de la Tijera F., et al.
LIVER INTERNATIONAL
, cilt.42, sa.3, ss.607-614, 2022 (SCI-Expanded, Scopus)
2022
202248. Evaluation of Magnetic Resonance Elastography and Transient Elastography for Liver Fibrosis and Steatosis Assessments in the Liver Transplant Setting
Ellik Z. M., İDİLMAN İ. S., Kartal A., Balaban Y., ELHAN A. H., KARÇAALTINCABA M., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.33, sa.2, ss.153-160, 2022 (SCI-Expanded, Scopus, TRDizin)
2022
202249. Performance of indirect immunofluorescence test and immunoblot tests in the evaluation of antinuclear and antimitochondrial antibodies
Ozturk O., DEMİRCİ DOS SANTOS DUARTE S., BALABAN H. Y., ŞİMŞEK H., Sener B.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.52, sa.5, ss.1697-1703, 2022 (SCI-Expanded, Scopus, TRDizin)
2021
202150. REAL LIFE EFFICACY AND TOLERABILITY OF TENOFOVIR ALAFENAMIDE FUMARATE IN PATIENTS WITH HEPATITIS B VIRUS-RELATED CIRRHOSIS AND LIVER TRANSPLANT RECIPIENTS. A-PRELIMINARY RESULT
YAPALI S., GÖKCAN H., Harputluoglu M., Ellik Z. M., AKARSU M., DURAK S., et al.
HEPATOLOGY
, cilt.74, 2021 (SCI-Expanded, Scopus)
2021
202151. EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN HEPATITIS B VIRUS-INFECTED PATIENTS WITH CHRONIC HEMODIALYSIS AND RENAL TRANSPLANTATION: A PRELIMINARY RESULT
ADANIR H., Etik D. O., YILDIRIM A. E., Mehdiyev S., YAPALI S., COŞAR A. M., et al.
HEPATOLOGY
, cilt.74, 2021 (SCI-Expanded, Scopus)
2021
202152. Recommendations for Hepatitis B Immunoglobulin and Antiviral Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation
AKARSU M., ÖNEM S., TURAN İ., Adali G., Akdogan M., Akyildiz M., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.32, sa.9, ss.712-719, 2021 (SCI-Expanded, Scopus)
2021
202153. Etiology of Cirrhosis in Turkey: A National Cohort Study
YILDIRIM A. E., ÜÇBİLEK E., Oruncu M. B., TURAN İ., DEMİR M., Koksal A., et al.
JOURNAL OF HEPATOLOGY
, cilt.75, 2021 (SCI-Expanded, Scopus)
2021
202154. Role of gastrointestinal system on transmission and pathogenesis of SARS-CoV-2
ŞİMŞEK C., Erul E., BALABAN H. Y.
WORLD JOURNAL OF CLINICAL CASES
, cilt.9, sa.20, ss.5427-5434, 2021 (SCI-Expanded, Scopus)
2021
202155. Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study
Efe C., Dhanasekaran R., Lammert C., Ebik B., Higuera-de la Tijera F., Aloman C., et al.
HEPATOLOGY
, cilt.73, sa.6, ss.2099-2109, 2021 (SCI-Expanded, Scopus)
2021
202156. Artificial intelligence method to predict overall survival of hepatocellular carcinoma
ŞİMŞEK C., GÜVEN D. C., Sahin T. K., TEKİN İ. E., Sahan O., BALABAN H. Y., et al.
Hepatology Forum
, cilt.2, sa.2, ss.64-68, 2021 (Scopus)
2021
202157. Artificial Intelligence to Predict Esophageal Varices in Patients with Cirrhosis
TEKİN İ. E., ŞİMŞEK C., BALABAN H. Y., ŞAHİN T. K.
Acıbadem Üniversitesi Sağlık Bilimleri Dergisi
, cilt.12, ss.625-629, 2021 (TRDizin)
2021
202158. Serum levels of inflammatory markers CRP, ESR and albumin in relation to survival for patients with hepatocellular carcinoma
AKKIZ H., Carr B. I., GÖZÜKARA BAĞ H. G., KARAOĞULLARINDAN Ü., Yalcin K., Ekin N., et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
, cilt.75, sa.2, 2021 (SCI-Expanded, Scopus)
2021
202159. An overview of SARS-COV-2 related hepatic injury
BALABAN H. Y., ASLAN A. T.
Hepatology forum
, 2021 (Scopus)
2021
202160. Artificial intelligence to predict overall survivals of patients with cirrhosis and outcomes of variceal bleeding
BALABAN H. Y., TEKİN İ. E., ŞAHİN T. K., SİVRİ B.
Hepatology forum
, 2021 (Scopus)
2021
202161. Machine Learning Models Predict Early Postoperative Relapse in Pancreatic Cancer
BALABAN H. Y., GÜVEN D. C., CEYLAN F., ÇAKIR İ. Y., ŞAHİN T. K., DİZDAR Ö., et al.
Journal of oncological sciences
, cilt.7, 2021 (Scopus, TRDizin)
2021
202162. A Case Report: When Autoantıbodıes are Together with Iron Overload, do not Judge a Book by Its Cover
KÖYLÜ B., BALABAN H. Y., SÖKMENSÜER C.
Hepatology forum
, 2021 (Scopus)
2021
202163. Retrospective Evaluation of Hepatitis C Awareness in Turkey Through Two Decades
BALABAN H. Y., DAĞ O., Alp A., Tseveldorj N., Vahabov C., GÖKTAŞ M. A., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.32, sa.1, ss.88-96, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202164. Lack of Awareness of Hepatitis B Screening and Vaccination in High-Risk Groups.
Balaban H. Y., Aslan A. T., Ayar Ş. N., DaĞ O., Alp A., ŞİmŞek C., et al.
Turkish journal of medical sciences
, cilt.51, ss.1229-1233, 2021 (SCI-Expanded, Scopus, TRDizin)
2020
202065. From nutrition to medicine: Assessing hemorrhoid healing activity of Solanum melongena L. via in vivo experimental models and its major chemicals
Donmez C., YALÇIN F. N., Boyacioglu O., KORKUSUZ P., Akkol E. K., NEMUTLU E., et al.
JOURNAL OF ETHNOPHARMACOLOGY
, cilt.261, 2020 (SCI-Expanded, Scopus)
2020
202066. Hepatitis E virus: Epidemiology, diagnosis, clinical manifestations, and treatment
Aslan A. T., BALABAN H. Y.
WORLD JOURNAL OF GASTROENTEROLOGY
, cilt.26, sa.37, ss.5543-5560, 2020 (SCI-Expanded, Scopus)
2020
202067. Plasma lipids, tumor parameters and survival in HCCpatients with HBV and HCV
AKKIZ H., CARR B., GUERRA V., DONGHİA R., YALÇIN K., KARAOĞULLARINDAN Ü., et al.
Journal of Translational Science
, sa.7, ss.1-6, 2020 (Hakemli Dergi)
2017
201768. Primer Karaciğer Kanserlerinde Tanı ve Klinik
BALABAN H. Y.
Kanser Gündemi , cilt.5, sa.3, ss.33-40, 2017 (TRDizin)
2017
201769. Liver immunology and herbal treatment
BALABAN H. Y., AKA C., KOCA ÇALIŞKAN U.
WORLD JOURNAL OF HEPATOLOGY
, cilt.9, sa.17, ss.757-770, 2017 (Scopus)
2017
201770. Intrahepatic Cholestasis of Pregnancy: Spontaneous vs in vitro Fertilization
BÖLÜKBAŞ F. F., BÖLÜKBAŞ C., BALABAN H. Y., İĞNAK S., aygün c., ergül e., et al.
Euroasian Journal of Hepato-Gastroenterology
, cilt.7, sa.2, ss.126-129, 2017 (Hakemli Dergi)
2017
201771. Alkol-Dışı Yağlı Karaciğer HastalığınınGüncel Tedavisinde Metformin ve UDKA’nınTemel veya Yardımcı Ajan Olarak Yeri Var mıdır?Ufuktaki Yeni Tedavi Ajanları Nelerdir?
BALABAN H. Y.
gÜncel gastroenteroloji , 2017 (Hakemsiz Dergi)
2016
201672. Acute temozolomide induced liver injury : Mixed type hepatocellular and cholestatic toxicity
AYGÜN C., YILDIRIM ALTINOK A., ÇAKIR A., AĞAN A. F., BALABAN H. Y.
ACTA GASTRO-ENTEROLOGICA BELGICA
, cilt.79, sa.4, ss.487-489, 2016 (SCI-Expanded, Scopus)
2016
201673. Acute temozolomide induced liver injury: mixed type hepatocellular and cholestatic toxicity
AYGÜN C., YILDIRIM ALTINOK A., ÇAKIR A., AĞAN A. F., Balaban Y.
ACTA GASTRO-ENTEROLOGICA BELGICA
, cilt.79, sa.3, ss.363-365, 2016 (SCI-Expanded, Scopus)
2014
201474. Gastric cancer prevention from the point of helicobacter
Balaban Y. H., ŞİMŞEK H., TATAR G.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.25, sa.4, ss.463-467, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
201475. Mature ovarian teratoma as a possible cause of fever and clinical exacerbation in Behçet’xxs disease: a case report
BALABAN H. Y.
MODERN RHEUMATOLOGY
, cilt.11, sa.2, ss.172-175, 2014 (SCI-Expanded, Scopus)
2013
201376. Detection of Resistance Mutations in Chronic Hepatitis B Patients Receiving Antiviral Therapy for Over One Year
AYDOĞAN S., ERGÜNAY K., Balaban Y., ALP A., Simsek H., TATAR G., et al.
MIKROBIYOLOJI BULTENI
, cilt.47, sa.3, ss.472-481, 2013 (SCI-Expanded, Scopus, TRDizin)
2013
201377. Detection of resistance mutations in chronic hepatitis B patients receiving antiviral therapy for over one year] Bir Yıldan Uzun Süreli Antiviral İlaç Kullanan Kronik Hepatit B Hastalarında Direnç Mutasyonlarının Saptanması
BALABAN H. Y.
Mikrobiyol Bul , cilt.47, ss.472-481, 2013 (TRDizin)
2012
201278. Alpha-1 antitrypsin deficiency in patients with chronic hepatitis
Şımşek H., Pinar A., Altinbaş A., Alp A., Balaban Y., Büyükaşik Y., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.23, sa.5, ss.569-573, 2012 (SCI-Expanded, Scopus, TRDizin)
2012
201279. Epidemiologic trends in HBV infections at a reference centre in Turkey: an 11-year retrospective analysis
ERGÜNAY K., Balaban Y., Cosgun E., Alp A., ŞİMŞEK H., Sener B., et al.
ANNALS OF HEPATOLOGY
, cilt.11, sa.5, ss.672-678, 2012 (SCI-Expanded, Scopus)
2012
201280. The genotype frequencies of IL28B polymorphisms (rs12979860, rs8099917) among Turkish patients with hepatitis C
Simsek H., ALP A., Yilmaz B., Balaban Y. H., ALTUN B., UZUN Ö., et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
, cilt.24, sa.9, ss.1113-1115, 2012 (SCI-Expanded, Scopus)
2012
201281. Mapping of Microsatellite Instability in Endoscopic Normal Colon
TUĞ E., BALABAN H. Y., ŞAHİN E.
GENETIC TESTING AND MOLECULAR BIOMARKERS
, cilt.16, sa.5, ss.388-395, 2012 (SCI-Expanded, Scopus)
2011
201182. A key problem and challenge for hepatology: Obesity-related metabolic liver diseases
Balaban Y. H.
WORLD JOURNAL OF HEPATOLOGY
, cilt.3, sa.6, ss.142-146, 2011 (ESCI, Scopus)
2011
201183. Cutoff Level to Detect Heterozygous Alpha 1 Antitrypsin Deficiency in Turkish Population
ŞİMŞEK H., PINAR A., Altinbas A., Alp A., Balaban Y. H., BÜYÜKAŞIK Y., et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS
, cilt.25, sa.4, ss.296-299, 2011 (SCI-Expanded, Scopus)
2010
201084. Do Gene Expressions Differ Between Gastritis with and without Helicobacter pylori?
Boran C., BALABAN H. Y., Yilmaz F.
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI
, cilt.30, sa.6, ss.1806-1813, 2010 (SCI-Expanded, Scopus)
2010
201085. The preventive effect of low molecular weight heparin on CCL4-induced necrosis and apoptosis in rat liver
KÜKNER A., TÖRE F., FIRAT T., TERZİ E. H., ÖNER H., Balaban Y. H., et al.
ANNALS OF HEPATOLOGY
, cilt.9, sa.4, ss.445-454, 2010 (SCI-Expanded, Scopus)
2010
201086. Efficacy of spironolactone therapy in patients with heart failure with normal ejection fraction
Ozhan H., BALABAN H. Y.
HEART
, cilt.96, sa.10, ss.791, 2010 (SCI-Expanded, Scopus)
2010
201087. Helicobacter pylori’nin Eşlik Ettiği ve Etmediği Gastritlerde Gen Ekspresyonları Farklı mıdır?
BALABAN H. Y.
Turkiye Klinikleri J Med Sci , cilt.30, sa.6, ss.1806-1813, 2010 (TRDizin)
2009
200988. Clinical utility of capsule endoscopy in small intestinal diseases, experience of single referral center with 125 cases
KAV T., Shorbagi A. I., SİVRİ B., Balaban Y. H., Arslan S., Batman F., et al.
PRZEGLAD GASTROENTEROLOGICZNY
, cilt.4, sa.5, ss.245-250, 2009 (SCI-Expanded, Scopus)
2008
200889. The power suction maneuver in single-balloon enteroscopy
Kav T., Balaban Y., Bayraktar Y.
ENDOSCOPY
, cilt.40, sa.11, ss.961-962, 2008 (SCI-Expanded, Scopus)
2008
200890. What is the optimum dose of adefovir in the treatment of chronic hepatitis B infection?
ŞİMŞEK H., Shorbagi A., Balaban Y., TATAR G.
JOURNAL OF HEPATOLOGY
, cilt.49, sa.3, ss.464-465, 2008 (SCI-Expanded, Scopus)
2008
200891. Causes of hypouricemia among outpatients
BUĞDAYCI G., Balaban Y., Sahin O.
LABMEDICINE
, cilt.39, sa.9, ss.550-552, 2008 (SCI-Expanded, Scopus)
2008
200892. Tumor markers in familial Mediterranean fever and their correlation with the frequency of attacks
Balaban Y. H., Simsek H., Yilmaz R., Sarer-Yurekli B. P., Shorbagi A., Tatar G.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.26, sa.4, 2008 (SCI-Expanded, Scopus)
2007
200793. Dipeptidyl peptidase IV (DDP IV) in NASH patients
Balaban Y. H., KORKUSUZ P., Simsek H., Gokcan H., Gedikoglu G., Pinar A., et al.
ANNALS OF HEPATOLOGY
, cilt.6, sa.4, ss.242-250, 2007 (SCI-Expanded, Scopus)
2007
200794. Solitary lipomatous polyp or lipoma of gastrointestinal tract: 3 case reports
Yilmaz F., Balaban Y. H., Sengul N., Boran C.
VIRCHOWS ARCHIV
, cilt.451, sa.2, ss.328, 2007 (SCI-Expanded, Scopus)
2007
200795. The difference in cyclin D1, HSP 105, EGFR, RB, and MSH2 gene expressions in chronic gastritis with and without helicobacter pylori infection
Boran C., Balaban Y., Yilmaz F.
VIRCHOWS ARCHIV
, cilt.451, sa.2, ss.318-319, 2007 (SCI-Expanded, Scopus)
2007
200796. Multinodular leiomyoma of the esophagus with internodular hydropic degeneration and bulbous serosal protrusions similar to cotyledonoid uterine leiomyoma
Boran C., Sengul N., BALABAN H. Y., Guerel S.
DISEASES OF THE ESOPHAGUS
, cilt.20, sa.2, ss.187-189, 2007 (SCI-Expanded, Scopus)
2007
200797. Wilson Hastalığı: Olgu Sunumu
BALABAN H. Y.
Dicle Tıp Dergisi , cilt.34, ss.57-60, 2007 (Hakemsiz Dergi)
2006
200698. HFE mutations analysis of Turkish patients with nonalcoholic steatohepatitis
Simsek H., Balaban Y. H., Sumer H., Yilmaz E., Tatar G.
DIGESTIVE DISEASES AND SCIENCES
, cilt.51, sa.10, ss.1723-1724, 2006 (SCI-Expanded, Scopus)
2005
200599. Mutations of the HFE gene among Turkish hereditary hemochromatosis patients
Simsek H., Balaban Y., Yilmaz E., Sumer H., Buyukasik Y., Cengiz C., et al.
ANNALS OF HEMATOLOGY
, cilt.84, sa.10, ss.646-649, 2005 (SCI-Expanded, Scopus)
2005
2005100. Alarming clarithromycin resistance of Helicobacter pylori in Turkish population
Simsek H., Balaban Y., Gunes D., Hascelik G., Ozarslan E., Tatar G.
HELICOBACTER
, cilt.10, sa.4, ss.360-361, 2005 (SCI-Expanded, Scopus)
2005
2005101. Coincidence or causality:: Celiac and Crohn diseases in a case of Turner syndrome
Durusu M., Gurlek A., Simsek H., Balaban Y., Tatar G.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES
, cilt.329, sa.4, ss.214-216, 2005 (SCI-Expanded, Scopus)
2005
2005102. Celiac disease in the Turkish population
Elsurer R., Tatar G., Simsek H., Balaban Y., Aydinli M., Sokmensuer C.
DIGESTIVE DISEASES AND SCIENCES
, cilt.50, sa.1, ss.136-142, 2005 (SCI-Expanded, Scopus)
2005
2005103. Familial Mediterranean fever (FMF) in Turkey - Results of a nationwide multicenter study
Tunca M., Akar S., Onen F., Ozdogan H., KASAPÇOPUR Ö., Yalcinkaya F., et al.
MEDICINE
, cilt.84, sa.1, ss.1-11, 2005 (SCI-Expanded, Scopus)
2004
2004104. Frequency of HFE mutations among Turkish blood donors according to transferrin saturation
Simsek H., Sumer H., Yilmaz E., Balaban Y., Ozcebe O., Hascelik G., et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY
, cilt.38, sa.8, ss.671-675, 2004 (SCI-Expanded, Scopus)
2004
2004105. Screening of tissue transglutaminase antibody in healthy blood donors for celiac disease screening in the Turkish population
Tatar G., Elsurer R., Simsek H., Balaban Y., Hascelik G., Ozcebe O., et al.
DIGESTIVE DISEASES AND SCIENCES
, cilt.49, sa.9, ss.1479-1484, 2004 (SCI-Expanded, Scopus)
2004
2004106. Panuveitis associated with multiple sclerosis complicated by cerebral venous thrombosis
Kadayifcilar S., Gedik S., Eldem B., Balaban H. Y., Kansu T.
OCULAR IMMUNOLOGY AND INFLAMMATION
, cilt.12, sa.2, ss.153-157, 2004 (SCI-Expanded, Scopus)
2004
2004107. Ameboma mimicking carcinoma of the cecum:: case report
Simsek H., Elsurer R., Sokmensuer C., Balaban H. Y., Tatar G.
GASTROINTESTINAL ENDOSCOPY
, cilt.59, sa.3, ss.453-454, 2004 (SCI-Expanded, Scopus)
2004
2004108. Ekstra-özefageal Reflü Hastalığı
BALABAN H. Y.
Hacettepe Tıp Dergisi , cilt.35, ss.3-6, 2004 (TRDizin)
2003
2003109. Diagnostic and therapeutic ERCP in hepatic hydatid disease
Simsek H., Ozaslan E., Sayek I., Savas C., Abbasoglu O., Soylu A., et al.
GASTROINTESTINAL ENDOSCOPY
, cilt.58, sa.3, ss.384-389, 2003 (SCI-Expanded, Scopus)
2001
2001110. Successful Weaning After Plasmapheresis Performed in a Patient with Myasthenic Crisis Proveked by Listeria Meningoencephalitis
BALABAN H. Y.
Turk Respir J , cilt.2, ss.44-46, 2001 (TRDizin)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2025
20251. Evaluation of the molecular basis of autoimmune cholestatic liver diseases via serum cytokine release
RADGOHAR A., BURUŞ A., ÜÇDAL M. T., YALÇINKAYA A., BALABAN H. Y., ÇELTİKÇİ B.
49th FEBS Congress, 05 Temmuz 2025, (Özet Bildiri)
2025
20252. Radgohar, A; Burus, A; Ucdal, M; Yalcinkaya, A; Balaban, Y; Celtikci, B. Evaluation of the molecular basis of autoimmune cholestatic liver diseases via serum cytokine release. FEBS OPEN BIO. 2025; 15 (Supp2), 450-451Meeting Abstract LB-R-41-07
BALABAN H. Y., BURUŞ A., ÜÇDAL M., ÇELTİKÇİ B.
FEBS OPEN BIO, Amerika Birleşik Devletleri, 01 Aralık 2025, (Tam Metin Bildiri)
2025
20253. Fonksiyonel Kabızlıkta Abdominal Masaj ile Birlikte Aerobik Egzersiz Eğitiminin Etkileri: Randomize Kontrollü Çalışma
DOĞAN İ. G., BALABAN H. Y., AKBAYRAK T., ŞİMŞEK C., ÖZGÜL S.
UGH2025, 25 - 30 Kasım 2025, (Tam Metin Bildiri)
2025
20254. Üniversite Öğrencilerinde Karaciğer Hastalıklarına Yönelik Damgalayıcı Tutumlar
BALABAN H. Y., TAŞKESEN İ., TAŞKESEN B., güniz Dogan b., ŞİMŞEK C., PARLAR Y. E.
ugh2025, Türkiye, 25 - 30 Kasım 2025, (Tam Metin Bildiri)
2025
20255. Karaciğer Sağlığı Bilgi ve Farkındalık Düzeyi
BALABAN H. Y., TAŞKESEN İ., ÇAKMAK M. F., güniz Dogan b., ŞİMŞEK C.
ugh2025, Türkiye, 25 - 30 Kasım 2025, (Tam Metin Bildiri)
2025
20256. THE ROLE OF KILLER IMMUNOGLOBULIN-LIKE RECEPTOR (KIR) GENE VARIANTS IN AUTOIMMUNE HEPATITIS AND PRIMARY BILIARY CHOLANGITIS: ASSOCIATION WITH DISEASE SEVERITY AND DEEP REMISSION
BALABAN H. Y., ÜÇDAL M., BURUŞ A., DAĞ O.
aasld2025, Amerika Birleşik Devletleri, 7 - 11 Kasım 2025, (Tam Metin Bildiri)
2025
20257. PATIENT CHARACTERISTICS OF ADULT CYSTIC FIBROSIS LIVER DISEASE AND THE EFFECTIVENESS OF NONINVASIVE FIBROSIS TESTS IN DETERMINING DISEASE STATUS
BALABAN H. Y., KAV T.
aasld2025, Amerika Birleşik Devletleri, 7 - 11 Kasım 2025, (Tam Metin Bildiri)
2025
20258. DIRECT BILIRUBIN-BASED MELD SCORE: IMPACT OF HEPATIC VS. EXTRA-HEPATIC HYPERBILIRUBINEMIA ON STAGING OF CIRRHOSIS
BALABAN H. Y., ÜÇDAL M., ŞENDUR İ., DAĞ O.
aasld2025, Amerika Birleşik Devletleri, 7 - 11 Kasım 2025, (Tam Metin Bildiri)
2025
20259. MULTI-AGENT LLM APPROACH VERSUS SINGLE MODEL IN THE MANAGEMENT OF NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING
BALABAN H. Y., ŞİMŞEK C., DURAK M. B., ÜÇDAL M.
ueg2025, Almanya, 4 - 07 Ekim 2025, (Tam Metin Bildiri)
2025
202510. ROLE OF NUCLEAR RECEPTOR COACTIVATOR 4 (NCOA4) GENE VARIANTS IN METABOLIC HYPERFERRITINEMIA OBSERVED IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH)
BALABAN H. Y., ÜÇDAL M., ŞİMŞEK C., BURUŞ A., ÇELTİKÇİ B.
eug2025, Almanya, 4 - 07 Ekim 2025, (Tam Metin Bildiri)
2025
202511. IMPACT OF A SUPERVISED COMBINED EXERCISE PROGRAM ON QUALITY OF LIFE IN PATIENTS WITH MASH: RESULTS FROM A RANDOMIZED CONTROLLED TRIAL
BALABAN H. Y., KUMBAROĞLU F. B., KARÇAALTINCABA M., PINAR A., KIZIL M., PARLAR Y. E., et al.
ueg2025, Almanya, 4 - 07 Ekim 2025, (Tam Metin Bildiri)
2025
202512. The role of flow-mediated dilation in assessing cardiovascular risk among patients with non-alcoholic fatty liver disease: A retrospective study
BALABAN H. Y., TOKGÖZOĞLU S. L., AYGÜN S.
EAS2025, İngiltere, 4 - 07 Mayıs 2025, (Tam Metin Bildiri)
2025
202513. MASLD Tanılı Hastalarda Kombine Egzersiz Programının Yaşam Kalitesi Üzerine Etkisi: Erken Sonuçlar
KUMBAROĞLU F. B., BALABAN H. Y., DÜGER T.
19. ULUSLARARASI FİZYOTERAPİDE GELİŞMELER KONGRESİ, Ankara, Türkiye, 09 Nisan 2025, (Özet Bildiri)
2025
202514. Fonksiyonel Kabızlıkta Abdominal Masaj ile Birlikte Aerobik Egzersiz Eğitiminin Etkileri: Randomize Kontrollü Çalışma
Doğan İ. G., ATABEY GERLEGİZ E. N., AKBAYRAK T., BALABAN H. Y., ŞİMŞEK C., ATAY B., et al.
42. Ulusal Gastroenteroloji Kongresi, Türkiye, 25 Kasım 2025, ss.67-69, (Özet Bildiri)
2024
202415. The Cytokine Profile of Primary Biliary Cholangitis (PBC): Is PBC an Autoinflammatory vs. Autoimmune Disease?
RADGOHAR A., ÜÇDAL M. T., BURUŞ A., YALÇINKAYA A., BALABAN H. Y., ÇELTİKÇİ B.
41. Ulusal Gastroenteroloji Haftası, Antalya, Türkiye, 27 Kasım 2024, (Özet Bildiri)
2024
202416. A Comprehensive Study on Gastroenterologists’ Beliefs, Attitudes, And Knowledge of Physical Activity and Exercise
KUMBAROĞLU F. B., DÜGER T., ÖZDEMİR P., BALABAN H. Y.
UEG Week, Viyana, Avusturya, 12 - 15 Ekim 2024, (Özet Bildiri)
2023
202317. Alkolsüz steatohepatit hastalarında yaşam kalitesi, yorgunluk, duygudurum ve hastalık belirteçleri arasındaki ilişkinin araştırılması.
KUMBAROĞLU F. B., BALABAN H. Y., DÜGER T.
9. Ulusal Fizyoterapi ve Rehabilitasyon Kongresi, Denizli, Türkiye, 26 Ekim 2023, sa.55, (Özet Bildiri)
2023
202318. IS HIGH AFP ASSOCIATED WITH LIVER DISEASES IN AUTOSOMAL RECESSIVE CEREBELLAR ATAXIAS?
BALABAN H. Y., YALÇIN ÇAKMAKLI G., ELİBOL B.
31st United European Gastroenterology Week 2023, viyana, Avusturya, 12 - 15 Ekim 2023, (Tam Metin Bildiri)
2022
202219. Wilson Hastalığı Tedavisinde Serum Değişken ve Göreceli Değişken Bakır Testleri 24 Saatlik İdrar Bakır Atılımına Alternatif Olabilir mi?
BALABAN H. Y., DURUKAN B. M., YALÇIN ÇAKMAKLI G., ŞAHİN T., ELİBOL B., DAĞ O.
39. Ulusal Gastroenteroloji Haftası, Antalya, Türkiye, 22 Kasım 2022, (Özet Bildiri)
2022
202220. EXCHANGEABLE AND RELATIVE EXCHANGEABLE COPPER CORRELATE WITH MULTIPARAMETRIC LIVER MRI PARAMETERS IN PATIENTS WITH WILSON DISEASE
BALABAN H. Y., DURUKAN B. M., YALÇIN ÇAKMAKLI G., İDİLMAN İ. S., ŞAHİN T., PINAR A., et al.
AASLD, Washington, Kiribati, 10 Kasım 2022, cilt.76, ss.1119-1120, (Özet Bildiri)
2022
202221. CAN SERUM EXCHANGEABLE AND RELATIVE EXCHANGEABLE COPPER BE ALTERNATIVE TESTS TO 24-HOUR URINARY COPPER EXCREATION IN PATIENTS ON TREATMENT FOR WILSON DISEASE?
BALABAN H. Y., DURUKAN B. M., YALÇIN ÇAKMAKLI G., PINAR A., ELİBOL B.
AASLD 2022, Amerika Birleşik Devletleri, 10 Kasım 2022, cilt.76, ss.1117, (Özet Bildiri)
2022
202222. EXCHANGEABLE AND RELATIVE EXCHANGEABLE COPPER LEVELS WERE SIMILAR IN WILSON DISEASE PATIENTS WITH AND WITHOUT OF CRANIAL MRI INVOLMENT
BALABAN H. Y., DURUKAN B. M., YALÇIN ÇAKMAKLI G., PARLAK Ş., ŞAHİN T., PINAR A., et al.
AASLD, Washington, Kiribati, 10 Kasım 2022, cilt.76, ss.1120-1121, (Özet Bildiri)
2022
202223. Preliminary results of the effectiveness and safety of Tenofovir Alefenamide Fumarate prophylaxis in HBV-infected individuals, who received chemo/immunosuppressive therapy
BALABAN H. Y., GÖKCAN H., YAPALI S., AKDOĞAN KAYHAN M., ŞİMŞEK H., İDİLMAN R.
EASL, Londrina, Brezilya, 23 Haziran 2022, cilt.77, ss.858, (Özet Bildiri)
2022
202224. Trends and causes of etiology in adult liver transplant patients: multicenter study
BALABAN H. Y., HARPUTLUOĞLU M. M. M., AKYILDIZ N. M., TURAN İ., GÜNŞAR F., KARASU A. Z., et al.
EASL, Londrina, Brezilya, 23 Haziran 2022, cilt.77, ss.820, (Özet Bildiri)
2022
202225. Real life efficacy and tolerability of Tenofovir alafenamde fumarate in liver transplant recipients: a multicenter study
BALABAN H. Y., GÖKCAN H., YAPALI S., GÜZELBULUT F., AKDOĞAN KAYHAN M., KIYICI M., et al.
EASL, Londrina, Brezilya, 23 Haziran 2022, cilt.77, ss.861, (Özet Bildiri)
2020
202026. Ayar, ŞN., Soyak, E., Şimşek, C., Çağdaş Ayvaz, DN., Balaban, Y. “Otoimmun Karaciğer Hastalarının Primer İmmün Yetmezlik Yönünden Değerlendirilmesi,” 37. Ulusal Gastroenteroloji Kongresi ve 8. Ulusal Gastroenteroloji Cerrahisi Kongresi - ONLINE KONGRE, SS – 031, 25-29 Kasım 2020.
BALABAN H. Y.
37. Ulusal Gastroenteroloji Kongresi ve 8. Ulusal Gastroenteroloji Cerrahisi Kongresi - ONLINE KONGRE, Türkiye, 25 - 29 Kasım 2020, (Tam Metin Bildiri)
2020
202027. Melekoglu Ellik, Z., Idilman, IS., Caliskan KartaL, A., Balaban, YH., karcaaltincaba, M., “Magnetic Resonance Elastography and Transient Elastograpghy to Assess Hepatic Stetaosis and Liver Fibrosis in the Liver Transplant Setting,” Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) Electronic Network, NOV 13-16, 2020, Hepatology,Vol. 72, Suppl 1 773A: Abstract 1289, 2020.
BALABAN H. Y.
Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) Electronic Network, 13 - 16 Kasım 2020
2020
202028. MAGNETIC RESONANCE ELASTOGRAPHY AND TRANSIENT ELASTOGRAPGHY TO ASSESS HEPATIC STETAOSIS AND LIVER FIBROSIS IN THE LIVER TRANSPLANT SETTING
Ellik Z. M., İDİLMAN İ. S., KARTAL A. Ç., Balaban Y. H., KARÇAALTINCABA M., İDİLMAN R.
Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), ELECTR NETWORK, 13 - 16 Kasım 2020, cilt.72, (Özet Bildiri)
2020
202029. Outcomes following deceased and live donor livertransplantation for the indication of acute liver failure: amulticenter experience
TURAN İ., ALADAĞ M., HARPUTLUOĞLU M. M. M., YILMAZ S., GENÇDAL G., POLAT K. Y., et al.
The Digital International Liver Congress (EASL) 2020, 27 - 29 Ağustos 2020, cilt.73, ss.227, (Özet Bildiri)
2019
201930. Proceedings of the World Congress of Gastroenterology
BALABAN H. Y., ASLAN A. T., AKDOĞAN KİTTANA F. N., ALP A., DAĞ O., AYAR Ş. N., et al.
World Congress of Gastroenterology, İstanbul, Türkiye, 21 Eylül 2019, cilt.30, ss.729, (Özet Bildiri)
2019
201931. Hepatitis B virus screening and immunization rates in special risk groups.
BALABAN H. Y., ASLAN A. T., AKDOĞAN F. N., ALP A., DAĞ O., AYAR Ş. N., et al.
World Congress of Gastroenterology 2019, 21 - 24 Eylül 2019, (Özet Bildiri)
2019
201932. The efficacy of abdominal massage in functional constipation: A randomized placebo-controlled trial
DOĞAN İ. G., ORHAN C., AKBAYRAK T., BALABAN H. Y., VAHABOV C., ÜZELPASACI E., et al.
World Congree of Gastroenterology 2019, 21 - 24 Eylül 2019, cilt.30, ss.725-726, (Özet Bildiri)
2019
201933. Hepatitis E virus epidemiology of patients with chronic hepatitis C in Turkey
BALABAN H. Y., ASLAN A. T., AKDOĞAN F. N., ALP A., DAĞ O., AYAR Ş. N., et al.
World Congress of Gastroenterology 2019, 21 - 24 Eylül 2019, (Özet Bildiri)
2019
201934. Hepatitis B virus screening and immunization rates in special risk groups
ŞİMŞEK H., BALABAN H. Y.
World Congress of Gastroenterology, İstanbul, Türkiye, 01 Ocak 2019
2019
201935. Hepatitis E virus epidemiology of patients with chronic hepatitis C in Turkey
ŞİMŞEK H., BALABAN H. Y.
World Congress of Gastroenterology, İstanbul, Türkiye, 01 Ocak 2019
2018
201836. Hepatitis E Virus Epidemiology and Genotype Analysis Among Special Risk Groups in Turkey, 16. Ulusal Hepato Gastroenteroloji Kongresi, 17-23 Ekim 2019-Girne, KKTC.
ASLAN A. T., BALABAN H. Y., AYAR Ş. N., AKDOĞAN KİTTANA F. N., ALP A., Vahabov C., et al.
16. Ulusal Hepato Gastroenteroloji Kongresi, Girne, Kıbrıs (Kktc), 31 Ekim 2018, (Özet Bildiri)
2018
201837. Hepatitis C Awareness Survey: Retrospective Evaluation of HCV Tests between 2000-2017
Balaban Y. H., DAĞ O., Alp A., PÜRNAK T., GÖKTAŞ M. A., Tseveldor N., et al.
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San-Francisco, Kostarika, 9 - 13 Kasım 2018, cilt.68, (Özet Bildiri)
2011
201138. Antiviral ilaç tedavisi alan kronik hepatit B hastalarında Entekavir ve Tenofovir direnç mutasyonlarının araştırılması
AYDOĞAN S., ERGÜNAY K., BALABAN H. Y., ALP A., ŞİMŞEK H., TATAR G., et al.
1. Ulusal Klinik Mikrobiyoloji Kongresi, Türkiye, 12 - 16 Kasım 2011, ss.59
2010
201039. THE THERAPEUTIC EFFECT OF LOW MOLECULAR WEIGHT HEPARIN ON CCL4-INDUCED NECROSIS AND APOPTOSIS IN RAT LIVER
Kukner A., Tore F., Firat T., Terzi E. H., Oner H., Balaban Y., et al.
45th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Vienna, Avusturya, 14 - 18 Nisan 2010, cilt.52, (Özet Bildiri)
2009
200940. Kronik karaciğer hastalarında alfa 1 antitripsin eksikliği
ŞİMŞEK H., BALABAN H. Y.
7. Ulusal Hepatoloji Kongresi, Türkiye, 01 Ocak 2009
2005
200541. Metabolic Syndrome, NASH and Hepatocyte Growth Factor
ŞİMŞEK H., TATAR G., BALABAN H. Y.
13th United European Gastroenterology Week (UEGW), Kopenak, 01 Ocak 2005
2004
200442. Kolon Kanserini Taklit Eden Bir Ameboma Vakası Kolonoskopi Cerrahiden Kurtarabilir mi?
ŞİMŞEK H., TATAR G., BALABAN H. Y.
I. Hepato Gastroenteroloji Kongresi, Türkiye, 01 Ocak 2004
2004
200443. Is CD26 (Dipeptidyl Peptidase IV) a Novel Candidate For Controlling NASH Pathogenesis?
ŞİMŞEK H., TATAR G., BALABAN H. Y.
12th United European Gastroenterology Week (UEGW), prag, 01 Ocak 2004
2003
200344. Kapsul Endoskopide Klinik Deneyimimiz: 4 Olgunun Sunumu
ŞİMŞEK H., TATAR G., BALABAN H. Y.
VI International Euroasian and Azerbaijanian Congress of Qastroenterologists and Surgeons, Baku, Azerbaycan, 01 Ocak 2003
2003
200345. Benign özefagus darliklarinin endoskopik tedavisi
ŞİMŞEK H., TATAR G., BALABAN H. Y.
VI International Euroasian and Azerbaijanian Congress of Qastroenterologists and Surgeons, Baku, Azerbaycan, 01 Ocak 2003
2003
200346. The Screening of Tissue Transglutaminase Antibody in Healty Blood Donors for the Celiac Disease Screening in Turkish Population
ŞİMŞEK H., BALABAN H. Y.
4th Congress of European Federation of Internal Medicine, Berlin, Almanya, 01 Ocak 2003
2003
200347. Son Bir Yillik ERCP Sonuçlarinin Önceki Yillarla Karşilaştirilması
ŞİMŞEK H., TATAR G., BALABAN H. Y.
VI International Euroasian and Azerbaijanian Congress of Qastroenterologists and Surgeons, Baku, Azerbaycan, 01 Ocak 2003
2003
200348. Celiac Disease in Turkish Population
ŞİMŞEK H., TATAR G., BALABAN H. Y.
4th Congress of European Federation of Internal Medicine, Berlin, Almanya, 01 Ocak 2003
2002
200249. Association of Helicobacter Pylori Infection with Familiar Mediterranean Fever Disease
ŞİMŞEK H., BALABAN H. Y.
3rd International Conference on Familial Mediterranean Fever and Hereditary Inflammatory Disorders, 01 Ocak 2002
2002
200250. Genotype Screening for Hereditary Hemochromatosis Among Voluntary Blood Donors in Turkey
ŞİMŞEK H., BALABAN H. Y.
Annual Meeting at Digestive Disease Week (DDW), 01 Ocak 2002
Kitaplar
2023
20231. Kolorektoanal Problemlerde Farmakolojik Tedavi
BALABAN H. Y., ŞİMŞEK C.
"Multidisipliner Balış Temeli" ile Pelvik Sağlıkta Fizyoterapi ve Rehabilitasyon, Türkan Albayrak, Serap özgül, Ceren Gürşen, Editör, Hedef Yayıncılık ve Mühendislik, Ankara, ss.249-258, 2023
Desteklenen Projeler
2023 - 2025
2023 - 2025Primer Biliyer Kolanjit ve Primer Sklerozan Kolanjit Patogenezinde İmmünoglobulinBenzeri Reseptörünün KIR ve İnsan Lökosit Antijeninin HLA Rolü
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
BALABAN H. Y. (Yürütücü), ÜÇDAL M. T., ÇELTİKÇİ B., RADGOHAR A., BURUŞ A., YALÇINKAYA A.
2021 - 2022
2021 - 2022Wilson Hastalarında Serum Değişken ve Göreceli Değişken Bakır Düzeylerinin Klinik Parametreler ve Multiparametrik Karaciğer MRI Bulgularıyla Karşılaştırılması
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
BALABAN H. Y. (Yürütücü), KARÇAALTINCABA M., İDİLMAN İ. S., PINAR A., SÖKMENSÜER C., DAĞ O., et al.
2020 - 2022
2020 - 2022NAFLD Hastalarında Karaciğer Hastalığının Evresi ile Serum Dallı Zincirli Amino asitler ve Fruktoz Düzeyi Arasındaki İlişkinin İncelenmesi
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
BALABAN H. Y. (Yürütücü), ŞAHİN T., Huseyinova S., AKSOY Y., COŞKUN T., KARÇAALTINCABA M., et al.
2019 - 2021
2019 - 2021
Yüksek Riskli Hasta Gruplarında
Kronik Hepatit C Akut Hepatit Hematopoietik Kök Hücre Nakli Böbrek Nakli
Hepatit E Virüsünün Taranması ve Genotiplendirilmesi
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
BALABAN H. Y. (Yürütücü), ALP A., HASÇELİK A. G., PÜRNAK T., ERGÜNAY K., DAĞ O., et al.